Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand

Contraception

Volumn 83, Issue 6, 2011, Pages 542-548

  Nanda, Kavita ^a   Morrison, Charles S ^a   Kwok, Cynthia ^a   Byamugisha, Josaphat ^b   Jones, Lashawn ^a   Sriplienchan, Somchai ^c   Magwali, Thulani ^d  

^a Family Health International   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Contraceptive discontinuation; Depot medroxyprogesterone acetate; HIV; Hormonal contraception; Oral contraceptives

Indexed keywords

CONTRACEPTIVE AGENT; DEPOT MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BLEEDING; BREAST TENDERNESS; COITUS; COMPARATIVE STUDY; CONDOM; CONTRACEPTION; CONTROLLED STUDY; COUNSELING; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NAUSEA; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; SIDE EFFECT; SURVIVAL; THAILAND; TREATMENT DURATION; UGANDA; VAGINITIS; ZIMBABWE;

ADOLESCENT; ADULT; AGE FACTORS; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV INFECTIONS; HUMANS; MEDROXYPROGESTERONE ACETATE; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; THAILAND; UGANDA; YOUNG ADULT; ZIMBABWE;

EID: 79955941139     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.09.003     Document Type: Article

References (27)

1. Population Reference B. Family Planning Worldwide 2008 Data Sheet. Washington (DC): PRB, 2008. Available at:http://www.prb.org/pdf08/fpds08.pdf.
2. Ali M, Cleland J. Contraceptive discontinuation in six developing countries: a cause-specific analysis. Int Fam Plan Perspect 1995;21:92-7.
3. Ali M, Cleland J. Oral contraceptive discontinuation and its aftermath in 19 developing countries. Contraception 2010;81:22-9.
4. Mahdy N, El-Zeiny N. Probability of contraceptive continuation and its determinants. East Mediterr Health J 1999;5:526-39.
5. Rakhshani F, Mohammadi M. Contraception continuation rates and reasons for discontinuation in Zahedan, Islamic Republic of Iran. East Mediterr Health J 2004;10:261.
6. Grady W, Hayward M, Florey F. Contraceptive discontinuation among married women in the United States. Stud Fam Plann 1988:227-35.
7. Ali M, Cleland J. Determinants of contraceptive discontinuation in six developing countries. J Biosoc Sci 1999;31:343-60. (Pubitemid 29355644)
8. Barden-O'Fallon J, Speizer I, Rodriguez F, Calix J. Experience with side effects among users of injectables, the IUD, and oral contraceptive pills in four urban areas of Honduras. Health Care Women Int 2009;30:475-83.
9. Lakha F, Henderson C, Glasier A. The acceptability of self-administration of subcutaneous Depo-Provera. Contraception 2005;72:14-8. (Pubitemid 40827112)
10. Sunyavivat S, Chumnijarakij T, Onthuam Y, Mehyar A. Reasons for discontinuing contraception among women in Bangkok. Bull World Health Organ 1983;61:861.
11. Stanwood N, Cohn S, Heiser J, Pugliese M. Contraception and fertility plans in a cohort of HIV-positive women in care. Contraception 2007;75:294-8. (Pubitemid 46389617)
12. UNAIDS. Report on the global HIV/AIDS epidemic 2008. Geneva (Switzerland): UNAIDS; 2008.
13. Reynolds H, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006;33:350.
14. Magalhães J, Amaral E, Giraldo P, Simoes J. HIV infection in women: impact on contraception. Contraception 2002;66:87-91. (Pubitemid 35245538)
15. Hoffman I, Martinson F, Powers K, Chilongozi D, Msiska E, Kachipapa E, et al. The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immun Defic Syndr 2008;47:477-83. (Pubitemid 351366969)
16. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007;21:85-95. (Pubitemid 44912541)
17. Steiner M, Kwok C, Dominik R, Byamugisha J, Chipato T, Magwali T, et al. Pregnancy risk among oral contraceptive pill, injectable contraceptive, and condom users in Uganda, Zimbabwe, and Thailand. Obstet Gynecol 2007;110:1003.
18. Narkavonnakit T, Bennett T, Balakrishnan T. Continuation of injectable contraceptives in Thailand. Stud Fam Plann 1982;13:99-105.
19. Zimbabwe Demographic and Health Survey, 1988. Calverton (MD): Central Statistical Office [Zimbabwe] and Macro International; 1989.
20. Zimbabwe Demographic and Health Survey 2005-06. Calverton (MD): Central Statistical Office [Zimbabwe] and Macro International; 2007.
21. Uganda Demographic and Health Survey 2000-2001. Calverton (MD): Uganda Bureau of Statistics and Macro International; 2001.
22. Tolley E, Loza S, Kafafi L, Cummings S. The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt. Int Fam Plan Perspect 2005;31:15-23.
23. Frost J, Darroch J. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspect Sex Reprod Health 2008;40:94-104.
24. Ott M, Adler N, Millstein S, Tschann J, Ellen J. The trade-off between hormonal contraceptives and condoms among adolescents. Perspect Sex Reprod Health 2002;34:6-14. (Pubitemid 36067315)
25. Yarnall K, McBride C, Lyna P, Fish L, Civic D, Grothaus L, et al. Factors associated with condom use among at-risk women students and nonstudents seen in managed care. Prev Med 2003;37:163-70. (Pubitemid 36802381)
26. Harel Z, Biro F, Kollar L, Rauh J. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health 1996;19:118-23. (Pubitemid 26274764)
27. Vaughan B, Trussell J, Kost K, Singh S, Jones R. Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth. Contraception 2008;78:271-83.